(158l) Spatially Controlled Cell-Free Protein Synthesis and Glycosylation on Chip | AIChE

(158l) Spatially Controlled Cell-Free Protein Synthesis and Glycosylation on Chip

Authors 

Manzer, Z. - Presenter, Cornell University
Aquino, A. K., Cornell University
DeLisa, M., Cornell University
Daniel, S., Cornell University
Among cellular processes, glycosylation of biomolecules like proteins or lipids is critical for their proper function and efficacy. Recombinant protein production is a highly conserved, templated process, while added glycans are extremely heterogenous and proper control over their expression is important in controlling biological activity and therapeutic function. Current cell-based methods to produce glycosylated biologics rely on native machinery, which inherently produces non-specific glycan profiles, making purification difficult as well as time and labor intensive. To solve these issues, cell-free technologies have been developed to produce proteins without growth constraints and allow the addition of cell-free glycosylation pathways.

I will describe our work towards a microfluidic platform analogous to the natural eukaryotic cellular assembly line, that integrates spatially separated cell-free protein synthesis, glycosylation, and enrichment of a model glycoprotein. Microfluidics allow for tight control over environmental conditions, recyclability of tethered enzymes, and importantly, separation of reactions that has yet to have been achieved in cell-free glycosylation systems. As an initial proof-of-concept, the green fluorescent protein (GFP) is used to allow easy visualization of cell-free protein production and purification. In the first module, GFP is expressed with continuous flow using E. coli cell-free extract. In the second module, the GFP with a terminal glycosylation tag is passed through a microfluidic chamber with glycosylation machinery. The current system uses the integral membrane oligosaccharyltransferase PglB, which efficiently transfers a heptasaccharide glycan from its lipid donor to the protein. For continuous production of glycoprotein, PglB is biotinylated and immobilized using the biotin-streptavidin interaction. In the third module, the GFP product is captured using immobilized affinity chromatography to allow for easy capture and subsequent release of the His-tag protein. This work presents a novel solution to cell-free systems that enables fundamental studies of glycosylation as well as being used for continuous cell-free glycoprotein production.